Correlation Between Ultranasdaq 100 and Pharmaceuticals Ultrasector

Can any of the company-specific risk be diversified away by investing in both Ultranasdaq 100 and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultranasdaq 100 and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ultranasdaq 100 Profund Ultranasdaq 100 and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Ultranasdaq 100 and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultranasdaq 100 with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultranasdaq 100 and Pharmaceuticals Ultrasector.

Diversification Opportunities for Ultranasdaq 100 and Pharmaceuticals Ultrasector

0.79

Correlation Coefficient

Ultranasdaq 100  Pharmaceuticals Ultrasector

Poor diversification

The 3 months correlation between Ultranasdaq and Pharmaceuticals is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Ultranasdaq 100 Profund Ultran and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Ultranasdaq 100 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultranasdaq 100 Profund Ultranasdaq 100 are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Ultranasdaq 100 i.e., Ultranasdaq 100 and Pharmaceuticals Ultrasector go up and down completely randomly.

Pair Corralation between Ultranasdaq 100 and Pharmaceuticals Ultrasector

Assuming the 90 days horizon Ultranasdaq 100 Profund Ultranasdaq 100 is expected to generate 1.51 times more return on investment than Pharmaceuticals Ultrasector. However, Ultranasdaq 100 is 1.51 times more volatile than Pharmaceuticals Ultrasector Profund. It trades about 0.06 of its potential returns per unit of risk. Pharmaceuticals Ultrasector Profund is currently generating about 0.0 per unit of risk. If you would invest  4,299  in Ultranasdaq 100 Profund Ultranasdaq 100 on February 14, 2025 and sell it today you would earn a total of  3,296  from holding Ultranasdaq 100 Profund Ultranasdaq 100 or generate 76.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.8%
Values	Daily Returns

Ultranasdaq 100 Profund Ultran  vs.  Pharmaceuticals Ultrasector Pr

Ultranasdaq 100 Profund

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ultranasdaq 100 Profund Ultranasdaq 100 has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Ultranasdaq 100 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharmaceuticals Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in June 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Ultranasdaq 100 and Pharmaceuticals Ultrasector

The main advantage of trading using opposite Ultranasdaq 100 and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultranasdaq 100 position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.

The idea behind Ultranasdaq 100 Profund Ultranasdaq 100 and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.